Abstract:Transient receptor potential canonical channels (TRPCs) are calcium-permeable, nonselective cation channels. Human TRPC channels contain six functional members: TRPC1, and TRPC3-7, and they are widely distributed in many tissues. These channels are involved in numerous physiological processes, including regulating myogenic tone and blood pressure, endothelial barrier function regulation, hypoxic pulmonary vasoconstriction, neuronal function, and kidney function. They are also associated with several diseases, including traumatic brain injury, pathologic cardiac hypertrophy, atherosclerosis, the development of cancer, and diabetes. Specifically, gain-of-function mutations of the TRPC6 gene in humans cause focal segmental glomerular sclerosis (FSGS), a chronic kidney disease for which there is no effective treatment. Consequently, TRPC channels serve as drug targets for several diseases, including FSGS and anxiety. Recent developments in single-particle cryo-EM permit the determination of the structures of multiple TRPC channel members (TRPC3, TRPC4, TRPC5, and TRPC6) in multiple states at near-atomic resolutions. These structures demonstrate that TRPC channels are tetramers composed of two layers: The upper transmembrane domain (TMD) and the lower intracellular domain (ICD). The ICD layer consists of ankyrin repeat domains (ARD), linker helices domains (LHD), the TRP helix, and C terminal helices. The four protomers' voltage sensor-like domains (VSLD) and pore domains form the TMD layer. ICD has a bell-like shape with a large central chamber and caps below TMD. The structures reveal both the inhibitory calcium binding site in ICD and the activating calcium binding site in TMD. Calcium binding to the inhibitory site results in the closure of the ICD and the restriction of ion flow through the ICD, whereas calcium dissociation from the inhibitory site results in the opening of the ICD and the unrestricted flow of ions through the ICD. Calcium binding to the activating site increases its activity. Additionally, the binding pockets and binding poses of several small molecule modulators of TRPC channels are identified. Their binding sites are distributed across three distinct regions of TMD. One of the pockets partially overlaps the endogenous activating lipid diacylglycerol-binding site, while another partially overlaps the activating calcium-binding site. In conclusion, these structural findings combined with functional analysis, particularly site-directed mutagenesis data, reveal how intracellular calcium concentrations bi-directionally modulate the TRPC channel, how small molecules bind and tune the activity of TRPC channels, and how the gain-of-function mutations found in FSGS patients over-activate the intracellular calcium signaling of kidney podocytes via the TRPC6 channel in a positive feedback manner. These developments lay the groundwork for a more in-depth mechanistic dissection of TRPC channels. They would also facilitate the discovery of drugs that target TRPC channels to treat associated diseases.

Calcium selective channel TRPV6: Structure, function, and implications in health and disease

A TRPV4 Channel C-terminal Folding Recognition Domain Critical for Trafficking and Function.

The TRPV6 Calcium Channel and Its Relationship with Cancer

Crystal structure of the epithelial calcium channel TRPV6

TRPV6 as A Target for Cancer Therapy

Exploring Functional Roles of TRPV1 Intracellular Domains with Unstructured Peptide-Insertion Screening.

What structures did, and did not, reveal about the function of the epithelial Ca2+ channels TRPV5 and TRPV6

Molecular Function Analysis on the Role of TRPV6 in the Onset of Digestive System Disease

Auto-inhibitory intramolecular S5/S6 interaction in the TRPV6 channel regulates breast cancer cell migration and invasion

Relationship between transient receptor potential vanilloid receptor 5,6 and bone metabolism

Structure-function analyses of human TRPV6 ancestral and derived haplotypes

Advances in the structural mechanism of TRPC channels

Advances in TRPV6 inhibitors for tumors by targeted therapies: Macromolecular protein, synthetic small molecule compounds, and natural compounds

TRPM channels in health and disease

Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites

TRPV3: Structure, Diseases and Modulators

Current understanding of mammalian TRP homologues

Calcium Entry through TRPV1: A Potential Target for the Regulation of Proliferation and Apoptosis in Cancerous and Healthy Cells

Autoinhibition of TRPV6 Channel and Regulation by PIP2

Recent advances on the structure and the function relationships of the TRPV4 ion channel

Research Progress on Post-translational Modification Regulate The Function of TRPV Channel